The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases
Open accessAbstract
Research on the use of biodegradable polymers for drug delivery has been ongoing since they were first used as bioresorbable surgical devices in the 1980s. For tissue engineering and drug delivery, biodegradable polymer poly-lactic-co-glycolic acid (PLGA) has shown enormous promise among all biomaterials. PLGA are a family of FDA-approved biodegradable polymers that are physically strong and highly biocompatible and have been extensively studied as delivery vehicles of drugs, proteins, and macromolecules such as DNA and RNA. PLGA has a wide range of erosion times and mechanical properties that can be modified. Many innovative platforms have been widely studied and created for the development of methods for the controlled delivery of PLGA. In this paper, the various manufacturing processes and characteristics that impact their breakdown and drug release are explored in depth. Besides different PLGA-based nanoparticles, preclinical and clinical applications for different diseases and the PLGA platform types and their scale-up issues will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wu, P., Zhou, Q., Zhu, H., Zhuang, Y., & Bao, J. (2020) · BMC Cancer · doi:10.1186/s12885-020-06803-7 · Cited by 97 · cited 2×
“but also greatly minimize side effects [72].”
BackgroundRetractedPoly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816 · cited 3×
“As shown in Figure 1, due to the presence of ester linkages that are degraded by hydrolysis in aqueous environments, it is controlled by polymer chemistry, such as glycoside unit content, initial molecular weight (MW) [30–32], stereochemistry (d and l composition) [1], or end-group functionalization [33].”
BackgroundBiodegradable polymers as biomaterials
Nair, L. S., & Laurencin, C. T. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.017 · Cited by 4,416
An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering
Gentile, P., Chiono, V., Carmagnola, I., & Hatton, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033640 · Cited by 1,593
Polymer microspheres for controlled drug release
Freiberg, S., & Zhu, X. X. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.04.013 · Cited by 1,336
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Pillai, O., & Panchagnula, R. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00227-1 · Cited by 710
PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
Chan, J. M., Zhang, L., Yuet, K. P., Liao, G., Rhee, J.-W., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.013 · Cited by 702
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Zhang, P., Sun, F., Liu, S., & Jiang, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.040 · Cited by 688
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01273-9 · Cited by 681
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 645
PLGA-Based Nanoparticles in Cancer Treatment
Rezvantalab, S., Drude, N. I., Moraveji, M. K., Güvener, N., Koons, E. K., Shi, Y., Lammers, T., & Kiessling, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01260 · Cited by 607
Recent advancements in liposome technology
Filipczak, N., Pan, J., Yalamarty, S. S. K., & Torchilin, V. P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.022 · Cited by 592
Polymeric micelles in cancer therapy: State of the art
Ghosh, B., & Biswas, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.016 · Cited by 546
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Tabatabaei Mirakabad, F. S., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 542
Tsai, Y.-M., Chien, C.-F., Lin, L.-C., & Tsai, T.-H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.06.030 · Cited by 535
Mukherjee, A., Waters, A. K., Kalyan, P., Achrol, A. S., Kesari, S., & Yenugonda, V. M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198353 · Cited by 493
Sustainable technologies for liposome preparation
Maja, L., Željko, K., & Mateja, P. (2020) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2020.104984 · Cited by 398
Jagannathan, R., Patel, S. A., Ali, M. K., & Narayan, K. M. V. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1161-2 · Cited by 369
Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery
Lu, B., Lv, X., & Le, Y. (2019) · Polymers · doi:10.3390/polym11020304 · Cited by 349
Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
Ghitman, J., Biru, E. I., Stan, R., & Iovu, H. (2020) · Materials & Design · doi:10.1016/j.matdes.2020.108805 · Cited by 328
PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up
Operti, M. C., Bernhardt, A., Grimm, S., Engel, A., Figdor, C. G., & Tagit, O. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120807 · Cited by 302
Liposome: composition, characterisation, preparation, and recent innovation in clinical applications
Ahmed, K. S., Hussein, S. A., Ali, A. H., Korma, S. A., Lipeng, Q., & Jinghua, C. (2019) · Journal of Drug Targeting · doi:10.1080/1061186x.2018.1527337 · Cited by 294
Recent advances in the formulation of PLGA microparticles for controlled drug delivery
Lagreca, E., Onesto, V., Di Natale, C., La Manna, S., Netti, P. A., & Vecchione, R. (2020) · Progress in Biomaterials · doi:10.1007/s40204-020-00139-y · Cited by 284
Vlachopoulos, A., Karlioti, G., Balla, E., Daniilidis, V., Kalamas, T., Stefanidou, M., Bikiaris, N. D., Christodoulou, E., Koumentakou, I., Karavas, E., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020359 · Cited by 277
McAloon, C. J., Boylan, L. M., Hamborg, T., Stallard, N., Osman, F., Lim, P. B., & Hayat, S. A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.026 · Cited by 274
Fan, S., Zheng, Y., Liu, X., Fang, W., Chen, X., Liao, W., Jing, X., Lei, M., Tao, E., Ma, Q., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461955 · Cited by 258
Zhu, G., Mei, L., Vishwasrao, H. D., Jacobson, O., Wang, Z., Liu, Y., Yung, B. C., Fu, X., Jin, A., Niu, G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01386-7 · Cited by 255
Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications
Dave, V., Tak, K., Sohgaura, A., Gupta, A., Sadhu, V., & Reddy, K. R. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.03.017 · Cited by 241
Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
Tsai, C.-H., Wang, P.-Y., Lin, I.-C., Huang, H., Liu, G.-S., & Tseng, C.-L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092830 · Cited by 240
Wang, Z., Ju, Y., Ali, Z., Yin, H., Sheng, F., Lin, J., Wang, B., & Hou, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-12142-4 · Cited by 232
Concepts and practices used to develop functional PLGA-based nanoparticulate systems
Sah, H., Desu, Sah, Wood, & Thoma (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40579 · Cited by 217
Epidemiology of Chronic Obstructive Pulmonary Disease
Ruvuna, L., & Sood, A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.05.002 · Cited by 201
Biomaterials for vaccine-based cancer immunotherapy
Zhang, R., Billingsley, M. M., & Mitchell, M. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.008 · Cited by 200
Injectable block copolymer hydrogels for sustained release of a PEGylated drug
Yu, L., Chang, G. T., Zhang, H., & Ding, J. D. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.026 · Cited by 197
Poly(Lactic-co-Glycolic Acid): Applications and Future Prospects for Periodontal Tissue Regeneration
Sun, X., Xu, C., Wu, G., Ye, Q., & Wang, C. (2017) · Polymers · doi:10.3390/polym9060189 · Cited by 194
Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
Pala, R., Anju, V., Dyavaiah, M., Busi, S., & Nauli, S. M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s250872 · Cited by 193
Iqbal, S., Blenner, M., Alexander-Bryant, A., & Larsen, J. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.9b01754 · Cited by 191
Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles
Partikel, K., Korte, R., Stein, N. C., Mulac, D., Herrmann, F. C., Humpf, H.-U., & Langer, K. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.05.006 · Cited by 184
Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases
Fang, G., Yang, X., Wang, Q., Zhang, A., & Tang, B. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112212 · Cited by 175
Hsu, J., Chu, S., Liao, C.-C., Wang, C., Wang, Y.-S., Lai, M., Wang, H.-C., Huang, H., & Tsai, M.-H. (2021) · Cancers · doi:10.3390/cancers13020195 · Cited by 166
Yu, L., Zhang, Z., & Ding, J. (2011) · Biomacromolecules · doi:10.1021/bm101572j · Cited by 160
Microfluidic assisted synthesis of PLGA drug delivery systems
Rezvantalab, S., & Keshavarz Moraveji, M. (2019) · RSC Advances · doi:10.1039/c8ra08972h · Cited by 160
Lee, Y. J., Lee, J.-H., Cho, H.-J., Kim, H. K., Yoon, T. R., & Shin, H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.051 · Cited by 159 · cited 2×
“from [33] and Figure (B) from [94] with copyright permission.”
BackgroundMethodRecent advances in nanomaterials for therapy and diagnosis for atherosclerosis
Chen, J., Zhang, X., Millican, R. C., Sherwood, J. A., Martin, S., Jo, H., Yoon, Y., Brott, B. C., & Jun, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.005 · Cited by 158
Feng, Q., Wu, J., Li, H., & Ma, G. (2018) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-018-1729-4 · Cited by 154
Lee, K. H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.001 · Cited by 149
El‐Hammadi, M. M., Delgado, Á. V., Melguizo, C., Prados, J. C., & Arias, J. L. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.012 · Cited by 148
Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles
Li, X., & Jiang, X. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.015 · Cited by 147
Babilotte, J., Martin, B., Gudurić, V., Bareille, R., Agniel, R., Roques, S., Héroguez, V., Dussauze, M., Gaudon, M., Nihouannen, D. L., et al. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111334 · Cited by 147
Zeb, A., Gul, M., Nguyen, T., & Maeng, H. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00584-w · Cited by 139
Yang, Y., Ding, Y., Fan, B. Q., Wang, Y., Mao, Z., Wang, W., & Wu, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.030 · Cited by 136
Maksimenko, O., Malinovskaya, J. A., Шипуло, Е. В., Osipova, N., Razzhivina, V., Arantseva, D., Yarovaya, O. V., Леонидовна, М. У., Khalansky, A. S., Федосеева, В. В., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118733 · Cited by 127
Periodontal regeneration using a bilayered PLGA/calcium phosphate construct
Reis, E. C. C., Borges, A. P. B., Araujo, M. V. F., Mendes, V. C., Guan, L., & Davies, J. E. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.040 · Cited by 126
Wang, P., Chu, W., Zhuo, X., Zhang, Y. X., Gou, J., Ren, T., He, H., Yin, T., & Tang, X. (2017) · Journal of Materials Chemistry B · doi:10.1039/c6tb02158a · Cited by 125
Zhang, L., Yang, S., Wong, L. R., Xie, H., & Ho, P. C. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00675 · Cited by 122
Self-assembled polymeric vesicles: Focus on polymersomes in cancer treatment
Araste, F., Aliabadi, A., Abnous, K., Taghdisi, S. M., Ramezani, M., & Alibolandi, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.027 · Cited by 121
Zhang, C., Yang, L., Wan, F., Bera, H., Cun, D., Rantanen, J., & Yang, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119441 · Cited by 116
Polymeric micelles as mighty nanocarriers for cancer gene therapy: a review
Yousefpour Marzbali, M., & Yari Khosroushahi, A. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3273-1 · Cited by 115
Raggi, P., Gadiyaram, V., Zhang, C., Chen, Z., Lopaschuk, G., & Stillman, A. E. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013104 · Cited by 113
Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications
Bose, R. J., Lee, S.-H., & Park, H. (2016) · Biomaterials Research · doi:10.1186/s40824-016-0081-3 · Cited by 109
Wu, J., Deng, C., Meng, F., Zhang, J., Sun, H., & Zhong, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.024 · Cited by 107
Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells
Nassir, A. M., Shahzad, N., Ibrahim, I. A. A., Ahmad, I., Md, S., & Ain, M. R. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.03.009 · Cited by 107
Sharma, A. K., Prasher, P., Aljabali, A. A. A., Mishra, V. K., Gandhi, H., Kumar, S., Mutalik, S., Chellappan, D. K., Tambuwala, M. M., Dua, K., et al. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00789-2 · Cited by 107
Kaur, J., Mishra, V. K., Singh, S. K., Gulati, M., Kapoor, B., Chellappan, D. K., Gupta, G., Dureja, H., Anand, K., Dua, K., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.014 · Cited by 106
Chiesa, E., Dorati, R., Modena, T., Conti, B., & Genta, I. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.044 · Cited by 104
Wang, J., Helder, L. S., Shao, J., Jansen, J. A., Yang, M., & Yang, F. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.023 · Cited by 104
Khaledi, S., Jafari, S., Hamidi, S., Molavi, O., & Davaran, S. (2020) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2020.1743946 · Cited by 104
Lian, M., Sun, B., Qiao, Z., Zhao, K., Zhou, X., Zhang, Q., Zou, D., He, C., & Zhang, X. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.12.071 · Cited by 102
Microfluidic Based Fabrication and Characterization of Highly Porous Polymeric Microspheres
Amoyav, B., & Benny, O. (2019) · Polymers · doi:10.3390/polym11030419 · Cited by 102
Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles
Nigam, K., Kaur, A., Tyagi, A. K., Nematullah, M., Khan, F., Gabrani, R., & Dang, S. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00622-5 · Cited by 102
Duse, L., Agel, M. R., Pinnapireddy, S. R., Schäfer, J., Selo, M. A., Ehrhardt, C., & Bakowsky, U. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11060282 · Cited by 101
Anterior Eye Segment Drug Delivery Systems: Current Treatments and Future Challenges
Molokhia, S. A., Thomas, S., Garff, K. J., Mandell, K. J., & Wirostko, B. M. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0241 · Cited by 100
Chen, Y., Chen, C., Zhang, X., He, C., Zhao, P., Li, M., Fan, T., Yan, R., Lu, Y., Lee, R. J., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.10.011 · Cited by 98
Shen, X., Li, T., Xie, X., Feng, Y., Chen, Z., Yang, H., Wu, C., Deng, S., & Liu, Y. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00381 · Cited by 97
Macromolecular design and preparation of polymersomes
Lefley, J., Waldron, C., & Becer, C. R. (2020) · Polymer Chemistry · doi:10.1039/d0py01247e · Cited by 96
Godara, S., Lather, V., Kirthanashri, S. V., Awasthi, R., & Pandita, D. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110576 · Cited by 95
Indocyanine Green J Aggregates in Polymersomes for Near-Infrared Photoacoustic Imaging
Changalvaie, B., Han, S., Moaseri, E., Scaletti, F., Truong, L., Caplan, R., Cao, A., Bouchard, R., Truskett, T. M., Sokolov, K. V., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b14519 · Cited by 93
Regulation of Drug Release by Tuning Surface Textures of Biodegradable Polymer Microparticles
Hussain, M., Xie, J., Hou, Z., Shezad, K., Xu, J., Wang, K., Gao, Y., Shen, L., & Zhu, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b02002 · Cited by 93
Arranz-Romera, A., Davis, B. M., Bravo‐Osuna, I., Esteban-Pérez, S., Molina-Martínez, I. T., Shamsher, E., Ravindran, N., Guo, L., Cordeiro, M. F., & Herrero‐Vanrell, R. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.012 · Cited by 90
Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs
Hashemi, M., Shamshiri, A., Saeedi, M., Tayebi, L., & Yazdian‐Robati, R. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108485 · Cited by 88
Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates
Park, J. Y., Mattessich, T., Jay, S. M., Agawu, A., Saltzman, W. M., & Fahmy, T. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.025 · Cited by 87
Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases
Vij, N., Min, T., Bodas, M., Gorde, A., & Roy, I. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.06.008 · Cited by 85
Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer
Rehman, U., Parveen, N., Sheikh, A., Abourehab, M. A. S., Sahebkar, A., & Kesharwani, P. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112766 · Cited by 83
Formulation of PLGA nano-carriers: specialized modification for cancer therapeutic applications
Chatterjee, M., & Chanda, N. (2021) · Materials Advances · doi:10.1039/d1ma00600b · Cited by 80
Chen, Y., Liang, Y., Jiang, P., Li, F., Yu, B., & Yan, F. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10188 · Cited by 77
Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer
Shukla, S. K., Kulkarni, N. S., Farrales, P., Kanabar, D. D., Parvathaneni, V., Kunda, N. K., Muth, A., & Gupta, V. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02790-3 · Cited by 70
Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management
Upadhaya, P. G., Pulakkat, S., & Patravale, V. B. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00747-y · Cited by 70
Grapa, C. M., Mocan, T., Gonciar, D., Zdrehuş, C., Moșteanu, O., Pop, T., & MOCAN, L. C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s226628 · Cited by 68
López-Cano, J. J., Sigen, A., Andrés‐Guerrero, V., Tai, H., Bravo‐Osuna, I., Molina-Martínez, I. T., Wang, W., & Herrero‐Vanrell, R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020234 · Cited by 68
Lü, Y., Wu, F., Duan, W., Mu, X., Fang, S., Lu, N., Zhou, X., & Kong, W. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110294 · Cited by 66
Surface Entrapment of Fibronectin on Electrospun PLGA Scaffolds for Periodontal Tissue Engineering
Campos, D. M., Gritsch, K., Salles, V., Attik, G., & Grosgogeat, B. (2014) · BioResearch open access · doi:10.1089/biores.2014.0015 · Cited by 65
Current Status of the New Antiepileptic Drugs in Chronic Pain
Sidhu, H. S., & Sadhotra, A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00276 · Cited by 65
Hong, S.-T., Lin, H., Wang, C.-S., Chang, C.-H., Lin, A. M.-Y., Yang, J. C., & Lo, Y. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0519-6 · Cited by 65
Shen, X., Li, T., Chen, Z., Xie, X., Zhang, H., Feng, Y., Li, S., Qin, X., Yang, H., Wu, C., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01321 · Cited by 64
Yin, Y., Wang, J., Yang, M., Du, R., Pontrelli, G., McGinty, S., Wang, G., Yin, T., & Wang, Y. (2020) · Nanoscale · doi:10.1039/c9nr08741a · Cited by 64
Abourehab, M. A. S., Ahmed, O. A. A., Balata, G. F., & Almalki, W. H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s168148 · Cited by 63
Bayındır, Z. S., Losada‐Barreiro, S., Bravo‐Díaz, C., Sova, M., Kristl, J., & Saso, L. (2021) · Antioxidants · doi:10.3390/antiox10050685 · Cited by 63
Afzal, I., Sarwar, H. S., Sohail, M. F., Varikuti, S., Jahan, S., Akhtar, S., Yasinzai, M., Satoskar, A. R., & Shahnaz, G. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0038 · Cited by 61
Maghrebi, S., Joyce, P. M., Jambhrunkar, M., Thomas, N., & Prestidge, C. A. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22991 · Cited by 56
Thanki, K., van Eetvelde, D., Geyer, A., Fraire, J. C., Hendrix, R., Eygen, H. V., Putteman, E., Sami, H., Carvalho‐Wodarz, C. D. S., Franzyk, H., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.004 · Cited by 55
Development of Polymer-Assisted Nanoparticles and Nanogels for Cancer Therapy: An Update
Neerooa, B. N. H. M., Ooi, L.-T., Shameli, K., Dahlan, N. A., Islam, J. M. M., Pushpamalar, J., & Teow, S. (2021) · Gels · doi:10.3390/gels7020060 · Cited by 55
Du, J., Li, X., Hu, H., Xu, L., Yang, S., & Li, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-21502-x · Cited by 54
Yokoyama, R., Ii, M., Tabata, Y., Hoshiga, M., Ishizaka, N., & Asahi, M. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0244 · Cited by 53
Caban-Toktas, S., Şahin, A., Lüle, S., Esendağlı, G., Vural, İ., Oğuz, K. K., Söylemezoğlu, F., Mut, M., Dalkara, T., Khan, M. A., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119076 · Cited by 53
Bao, S., Zheng, H., Ye, J., Huang, H., Zhou, B., Yao, Q., Lin, G., Zhang, H., Kou, L., & Chen, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.625084 · Cited by 53
Zhou, J., Zhai, Y., Xu, J., Zhou, T., & Cen, L. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120173 · Cited by 52
Operti, M. C., Fecher, D., van Dinther, E. A. W., Grimm, S., Jaber, R., Figdor, C. G., & Tagit, O. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.044 · Cited by 51
Dinakaran, D., Sengupta, J., Pink, D., Raturi, A., Chen, H., Usmani, N., Kumar, P., Lewis, J. D., Narain, R., & Moore, R. B. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.09.029 · Cited by 51
Sokolova, V., Kostka, K., Shalumon, K. T., Prymak, O., Chen, J., & Epple, M. (2020) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-020-06442-1 · Cited by 51
Roth‐Walter, F., Adcock, I. M., Benito‐Villalvilla, C., Bianchini, R., Bjermer, L. H., Caramori, G., Cari, L., Chung, K. F., Diamant, Z., Eguíluz‐Gracia, I., et al. (2018) · Allergy · doi:10.1111/all.13642 · Cited by 50
Ospina‐Villa, J. D., Hoyos, C. G., Zuluaga, R., & Triana‐Chávez, O. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.05.004 · Cited by 50
Caminal, M., Peris, D., Fonseca, C., Barrachina, J., Codina, D., Rabanal, R. M., Moll, X., Morist, A., García, F., Cairó, J. J., et al. (2015) · Cytotechnology · doi:10.1007/s10616-015-9842-4 · Cited by 49
Takeuchi, I., Kagawa, A., & Makino, K. (2020) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2020.124866 · Cited by 49
Targeting COPD with PLGA‐Based Nanoparticles: Current Status and Prospects
Saxena, J., Bisen, M., Misra, A., Kumar, V., Kaushik, S., Siddiqui, A. J., Mishra, N., Singh, A., & Jyoti, A. (2022) · BioMed Research International · doi:10.1155/2022/5058121 · Cited by 48
Hu, F., Zhang, R., Guo, W., Yan, T., He, X., Hu, F., Ren, F., Ma, X., Lei, J., & Zheng, W. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00321 · Cited by 47
Agossa, K., Lizambard, M., Rongthong, T., Delcourt‐Debruyne, E., Siepmann, J., & Siepmann, F. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.039 · Cited by 46
PLGA Based Nanoparticles for the Monocyte-Mediated Anti-Tumor Drug Delivery System
Allavena, P., Palmioli, A., Avigni, R., Sironi, M., Ferla, B. L., & Maeda, A. (2020) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2020.2881 · Cited by 45
Handali, S., Moghimipour, E., Rezaei, M., Ramezani, Z., & Dorkoosh, F. A. (2019) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2019.1684945 · Cited by 44
Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer’s disease
Handa, M., Tiwari, S., Yadav, A. K., Almalki, W. H., Alghamdi, S. A., Alharbi, K. S., Shukla, R., & Beg, S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.020 · Cited by 44
d’Avanzo, N., Bruno, M. C., Giudice, A., Mancuso, A., Gaetano, F. D., Cristiano, M. C., Paolino, D., & Fresta, M. (2021) · Molecules · doi:10.3390/molecules26061643 · Cited by 43
The potential of lipid-polymer nanoparticles as epigenetic and ROS control approaches for COPD
Chikuma, K., Arima, K., Asaba, Y., Kubota, R., Asayama, S., Sato, K., & Kawakami, H. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1696965 · Cited by 42
Ashhurst, A. S., Parumasivam, T., Chan, J. G. Y., Lin, L. C. W., Flórido, M., West, N. P., Chan, H., & Britton, W. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194620 · Cited by 40
Hänggi, D., Etminan, N., Mayer, S. A., Aldrich, E. F., Diringer, M. N., Schmutzhard, E., Faleck, H. J., Ng, D., Saville, B. R., Macdonald, R. L., et al. (2018) · Neurocritical Care · doi:10.1007/s12028-018-0575-z · Cited by 38
Esfandyari‐Manesh, M., Abdi, M., Talasaz, A. H., Ebrahimi, S. M., Atyabi, F., & Dinarvand, R. (2020) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00324-w · Cited by 38
Ali, S., Amin, M. U., Tariq, I., Sohail, M. F., Ali, M. Y., Preis, E., Ambreen, G., Pinnapireddy, S. R., Jedelská, J., Schäfer, J., et al. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s285950 · Cited by 38
Morelli, L., Gimondi, S., Sevieri, M., Salvioni, L., Guizzetti, M., Colzani, B., Palugan, L., Foppoli, A., Talamini, L., Morosi, L., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120658 · Cited by 37
PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities
Zhang, Y., García‐Gabilondo, M., Grayston, A., Feiner, I. V. J., Anton‐Sales, I., Loiola, R. A., Llop, J., Ramos‐Cabrer, P., Barba, I., David Garcia-dorado, A., et al. (2020) · Nanoscale · doi:10.1039/c9nr10620k · Cited by 37
Preparation and analysis of a sustained drug delivery system by PLGA–PEG–PLGA triblock copolymers
Khodaverdi, E., Hadizadeh, F., Tekie, F. S. M., Afshin, J., Mohajeri, S. A., & Ganji, F. (2012) · Polymer Bulletin · doi:10.1007/s00289-012-0747-5 · Cited by 35
Fornaguera, C., Feiner‐Gracia, N., Calderó, G., García, M. J. N., & Solans, C. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.08.001 · Cited by 34
Nigam, K., Kaur, A., Tyagi, A., Manda, K., Gabrani, R., & Dang, S. (2018) · Rejuvenation Research · doi:10.1089/rej.2018.2119 · Cited by 33
Dimchevska, S., Geškovski, N., Koliqi, R., Matevska-Geshkovska, N., Gómez‐Vallejo, V., Szczupak, B., Sebastian, E. S., Llop, J., Hristov, D. R., Monopoli, M. P., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.054 · Cited by 32
Chung, C. H. Y., Cui, B., Song, R., Liu, X., Xu, X., & Yao, S. (2019) · Micromachines · doi:10.3390/mi10090592 · Cited by 32
Efthimiadou, E. Κ., Tapeinos, C., Bilalis, P., & Kordas, G. C. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0579-5 · Cited by 31
Ribeiro, A. F., dos Santos, J. F., de Mattos, R. M., Barros, E. G. D. O., Nasciutti, L. E., Cabral, L. M., & de Sousa, V. P. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020190336 · Cited by 31
Upadhyay, P., Bhattacharjee, M., Bhattacharya, S., Ahir, M., Adhikary, A., & Patra, P. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00987 · Cited by 27
Brauner, B., Semmler, J., Rauch, D., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c01745 · Cited by 24
Inhaled Simvastatin Nanoparticles for Inflammatory Lung Disease
Tulbah, A. S., Pisano, E., Scalia, S., Young, P. M., Traini, D., & Ong, H. X. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0188 · Cited by 21
Wang, T., & Luo, Y. (2021) · Nano Research · doi:10.1007/s12274-021-3450-8 · Cited by 20
Smirnova, V. V., Chausov, D. N., Serov, D. A., Козлов, В. А., Ivashkin, P. I., Pishchalnikov, R. Y., Уваров, О. В., Vedunova, M. V., Semenova, A., Lisitsyn, A. B., et al. (2021) · Materials · doi:10.3390/ma14226915 · Cited by 20
Emerging therapeutic strategies in COPD
Babu, K. S., & Morjaria, J. B. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.003 · Cited by 19
Farid, E. A., Davachi, S. M., Pezeshki‐Modaress, M., Taranejoo, S., Seyfi, J., Hejazi, I., Hakim, M. T., Najafi, F., D’Amico, C., & Abbaspourrad, A. (2020) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2020.1725863 · Cited by 19
Choi, Y.-S., Joo, J.-R., Hong, A., & Park, J.-S. (2011) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2011.32.3.867 · Cited by 17
Estupiñán, Ó., Rendueles, C., Suárez, P., Rey, V., Murillo, D., Morís, F., Gutiérrez, G., Blanco‐López, M. C., Matos, M., & Rodrı́guez, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071358 · Cited by 17
Novel Therapeutic Strategy in the Management of COPD: A Systems Medicine Approach
Lococo, F., Cesario, A., Bufalo, A. D., et al. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150904113032 · Cited by 15
Varani, M., Galli, F., Capriotti, G., Mattei, M., Cicconi, R., Campagna, G., Panzuto, F., & Signore, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061750 · Cited by 14
Tailor-made oligonucleotide-loaded lipid-polymer nanosystems designed for bone gene therapy
García‐García, P., Briffault, E., Landín, M., Évora, C., Díaz‐Rodríguez, P., & Delgado, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00926-5 · Cited by 14
Three core-shell polymersomes for targeted doxorubicin delivery: Sustained and acidic release
Liu, H., Gong, L., Lü, S., Wang, H., Fan, W., & Yang, C. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102293 · Cited by 11
Polymeric Nanoparticles Explored for Drug-Delivery Applications
Asem, H., & Malmström, E. (2018) · ACS symposium series · doi:10.1021/bk-2018-1296.ch016 · Cited by 10
Cited by
Recent Applications of PLGA in Drug Delivery Systems
Yang, J., Zeng, H., Luo, Y., Chen, Y., Wang, M., Wu, C., & Hu, P. (2024) · Polymers · doi:10.3390/polym16182606 · Cited by 268
PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy
Kesharwani, P., Kumar, V., Goh, K. W., Gupta, G., Alsayari, A., Wahab, S., & Sahebkar, A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02410-x · Cited by 132
“PLGA is a polymer that is both biocompatible and biodegradable [61].”
PLGA-Based Co-Delivery Nanoformulations: Overview, Strategies, and Recent Advances
Stevanović, M. M., Qian, K., Huang, L., & Vukomanović, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121613 · Cited by 42
Clinical translation of nanomedicines for brain diseases: Current challenges and future directions
Wang, G., Wang, N., Xia, X., Ismail, M., & Shi, B. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114426 · Cited by 33
Metadata
- Authors
- Alsaab, H. O., Alharbi, F. D., Alhibs, A. S., Alanazi, N. B., Alshehri, B. Y., Saleh, M. A., Alshehri, F. S., Algarni, M. A., Almugaiteeb, T., Uddin, M. N., & Alzhrani, R. M.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2022-12-06
- Volume
- 14
- Issue
- 12
- Pages
- 2728
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W4311717363
- Cited by
- 289
- References
- 149
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.